2.02

0.49% -0.010

After Hours: 1.95 -0.07 -3.47%

Stereotaxis Inc (STXS)

Overview News Price History Option Chain Discussions Forecast Stock Split

Stereotaxis Inc stock is traded at $2.02, with a volume of 400.94K. It is down -0.49% in the last 24 hours and down -21.09% over the past month. Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to design and develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.

Previous Close:

$2.03

Open:

$2.04

24h Volume:

400.94K

Relative Volume:

0.70

Market Cap:

$188.52M

Revenue:

$25.14M

Net Income/Loss:

$-21.57M

P/E Ratio:

-7.4815

EPS:

-0.27

Net Cash Flow:

$-12.23M

1W Performance:

+2.02%

1M Performance:

-21.09%

6M Performance:

-24.06%

1Y Performance:

-6.05%

1-Day Range:

$1.965

$2.04

1-Week Range:

$1.965

$2.1581

52-Week Range:

$1.54

$3.59

Stereotaxis Inc Stock (STXS) Company Profile

Name

Stereotaxis Inc

Sector

Healthcare (1112)

Industry

Medical Instruments & Supplies (58)

Phone

314-678-6100

Address

4320 Forest Park Avenue, Suite 100, St. Louis, MO

Employee

118

Twitter

@stereotaxis

Next Earnings Date

2025-03-03

Latest SEC Filings

STXS's Discussions on Twitter

Compare STXS vs ISRG, BDX, ALC, MDLN, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
STXS Stereotaxis Inc	2.02	189.45M	25.14M	-21.57M	-12.23M	-0.27
ISRG Intuitive Surgical Inc	478.60	176.19B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	177.81	51.41B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	78.55	39.00B	10.19B	1.05B	1.38B	2.1044
MDLN Medline Inc	44.59	37.48B	27.43B	1.27B	1.01B	1.5829
RMD Resmed Inc	245.73	37.82B	5.40B	1.49B	1.78B	10.12

Stereotaxis Inc Stock (STXS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-16-25	Initiated	Citizens JMP	Mkt Outperform
Jan-10-24	Initiated	ROTH MKM	Buy
Jul-12-22	Initiated	Aegis Capital	Buy
Jun-23-22	Initiated	B. Riley Securities	Buy
Jan-05-22	Initiated	Craig Hallum	Buy
Jan-05-22	Initiated	Loop Capital	Buy
May-26-21	Initiated	Piper Sandler	Overweight
Sep-08-20	Initiated	Northland Capital	Outperform
Apr-09-20	Initiated	Cowen	Outperform
Apr-07-20	Initiated	Lake Street	Buy